Literature DB >> 16143360

Impact of macrophage and dendritic cell subset elimination on antiviral immunity, viral clearance and production of type 1 interferon.

Richard P Ciavarra1, Lisa Taylor, Amy R Greene, Nazita Yousefieh, Dale Horeth, Nico van Rooijen, Christina Steel, Betsy Gregory, Mark Birkenbach, Margaret Sekellick.   

Abstract

We report herein that vesicular stomatitis virus (VSV) induced a concurrent primary Th1 (T helper 1) and Th2 cytokine response detectable ex vivo. Liposome-encapsulated clodronate-mediated elimination of CD8- marginal dendritic cells (DCs) and splenic macrophages (m Phi), but not CD8+ interdigitating DCs, prior to infection resulted in a markedly diminished chemokine and Th1 (IL-2, interferon-gamma) cytokine response, although the Th2 response (IL-4) remained relatively intact. Repopulation with marginal DCs and marginal metallophilic macrophages (MMM) restored Th1 cytokine profiles but did not restore chemokine responsiveness or reduce VSV-induced morbidity/mortality. Chemokine competency returned approximately 4 weeks post-depletion, which correlated temporally with repopulation of the spleen with marginal zone macrophages (MZM) and red pulp macrophages (RPM). Unexpectedly, virus-induced morbidity persisted for over 1 month post-depletion and was associated with virus dissemination and distinctive histological lesions in the liver. Depletion of interferon-producing plasmacytoid dendritic cells did not account for virus-induced morbidity because serum levels of type I interferon were not diminished in Cl2MBP-liposome-treated mice. Thus, distinct m Phi subsets are critical for chemokine production and viral clearance, and, in their absence, VSV disseminates even in the presence of high titers of interferon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143360     DOI: 10.1016/j.virol.2005.07.031

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  T cell and APC dynamics in situ control the outcome of vaccination.

Authors:  Kamal M Khanna; David A Blair; Anthony T Vella; Stephen J McSorley; Sandip K Datta; Leo Lefrançois
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 2.  Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history.

Authors:  Patricia Fitzgerald-Bocarsly; Jihong Dai; Sukhwinder Singh
Journal:  Cytokine Growth Factor Rev       Date:  2008-01-11       Impact factor: 7.638

3.  The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon.

Authors:  Chen Wang; Taoyong Chen; Jia Zhang; Mingjin Yang; Nan Li; Xiongfei Xu; Xuetao Cao
Journal:  Nat Immunol       Date:  2009-05-31       Impact factor: 25.606

4.  Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses.

Authors:  Hideo Negishi; Hideyuki Yanai; Akira Nakajima; Ryuji Koshiba; Koji Atarashi; Atsushi Matsuda; Kosuke Matsuki; Shoji Miki; Takahiro Doi; Alan Aderem; Junko Nishio; Stephen T Smale; Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Immunol       Date:  2012-05-20       Impact factor: 25.606

5.  B cells, not just for antibody anymore.

Authors:  Kamal M Khanna; Leo Lefrançois
Journal:  Immunity       Date:  2012-03-23       Impact factor: 31.745

6.  B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity.

Authors:  E Ashley Moseman; Matteo Iannacone; Lidia Bosurgi; Elena Tonti; Nicolas Chevrier; Alexei Tumanov; Yang-Xin Fu; Nir Hacohen; Ulrich H von Andrian
Journal:  Immunity       Date:  2012-03-01       Impact factor: 31.745

7.  Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNS.

Authors:  Christina D Steel; Woong-Ki Kim; Larry D Sanford; Laurie L Wellman; Sandra Burnett; Nico Van Rooijen; Richard P Ciavarra
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

8.  Vesicular stomatitis virus oncolytic treatment interferes with tumor-associated dendritic cell functions and abrogates tumor antigen presentation.

Authors:  Simon Leveille; Marie-Line Goulet; Brian D Lichty; John Hiscott
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

9.  Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice.

Authors:  Silvio Antoniak; Kohei Tatsumi; Michael Bode; Swetha Vanja; Julie C Williams; Nigel Mackman
Journal:  J Innate Immun       Date:  2016-11-08       Impact factor: 7.349

10.  The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis.

Authors:  Patric Lundberg; Chandran Ramakrishna; Jeffrey Brown; J Michael Tyszka; Mark Hamamura; David R Hinton; Susan Kovats; Orhan Nalcioglu; Kenneth Weinberg; Harry Openshaw; Edouard M Cantin
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.